Catching up with the first children to receive the RTS,S malaria vaccine in Malawi, one year later.
-
MVI Portfolio
We strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity. -
Evaluation technology projects
We partner to develop and optimize new assays and challenge models and support reference and service laboratories. -
RTS,S
RTS,S/AS01 (RTS,S) is the world’s first malaria vaccine shown to provide partial protection against malaria in young children.